Nirsevimab therapy showed 83% effectiveness in preventing RSV-associated bronchiolitis hospitalizations in infants under 12 months. The study demonstrated significant efficacy against severe RSV cases ... News Medical: Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis Although inhaled epinephrine (adrenaline) has been found to reduce the need for hospitalization when given to patients with bronchiolitis in the emergency department, it is not clear whether ...
The American Journal of Managed Care: Nirsevimab Reduces Risk of RSV-Associated Bronchiolitis, Study Finds Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal ... A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis - a seasonal viral ... Healio: More hospitalized children avoid ICU with high-flow nasal cannula bronchiolitis treatment Please provide your email address to receive an email when new articles are posted on . Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU ...
